A Rare Presentation of Langerhans Cell Histiocytosis Tonsil Infiltration: Review of the Literature: Atypical Presentation of Langerhans Cell Histiocytosis

被引:0
作者
Figen Atalay
Eltaf Ayça Özbal Koç
Semsi Yıldız
机构
[1] Baskent University,Department of Hematology, School of Medicine
[2] Baskent University,Department of Otolaryngology, School of Medicine
[3] Baskent University,Department of Pathology, School of Medicine
[4] Başkent Üniversitesi İstanbul Saglık Uygulama ve Arastırma Merkezi Hastanesi,undefined
来源
Indian Journal of Hematology and Blood Transfusion | 2014年 / 30卷
关键词
Langerhans cell histiocytosis; Tonsillar neoplasms; Prednisolone;
D O I
暂无
中图分类号
学科分类号
摘要
Langerhans cell histiocytosis (LCH) is a rare disease that can infiltrate various organs. LCH presents with solitary organ involvement or as a multi-system disease. We present a patient who has tonsillary infiltration with LCH. A 74 year-old Caucasian male was admitted for swelling of the neck and difficulty swallowing for 3 months. Physical examination showed submandibular lymph node enlargement of approximately 3 cm and tonsil enlargement. A tonsillectomy and excisional biopsy of the lymph node were done. Histiocyte-like cell infiltration was seen in the tonsil biopsy. CD3, CD20, CD15, CD30, CD5, CD138, Lambda, Kappa, Bcl-2, ALK, CD23, CD10, Bcl-6, keratin, EMA, HMB-45, and Cyl D1 were negative. CD68, S-100, CD1a, and fascin were positive, and the Ki-67 proliferation index was 20 % in immunocytochemical staining. The most commonly infiltrated bones are the skull, femur, lower jaw, pelvis, and vertebrae in LCH. Oral or perioral lesions are present in 30 % of cases. Oral lesions most often involve bone loss, unexpected tooth loss, and gum inflammation. We administered oral prednisolone to our patient due to the presence of lytic lesion of the bone, mild anemia and a higher sedimentation rate, which was from a separate, explained cause. Isolated tonsillar involvement in adult LCH was reported in only 2 cases in the literature. There is no standard recommendation for treatment. Our patient responded well to steroid therapy.
引用
收藏
页码:437 / 439
页数:2
相关论文
共 36 条
  • [1] Haupt R(2013)Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years Pediatr Blood Cancer 60 175-184
  • [2] Minkov M(1987)Histiocytosis syndromes in children Lancet 1 208-209
  • [3] Astigarraga I(2012)Langerhans cell histiocytosis diagnosed in an elderly patient Radiol Bras 45 241-243
  • [4] lyeyasu JN(2002)Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker Am J Clin Pathol 118 335-343
  • [5] Marcos Vaz AC(2012)Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review World J Gastroenterol 18 1410-1413
  • [6] Reis F(2012)Oral manifestations of Langerhans cell histiocytosis (LCH): review of scientific literature and case report Rev Odontol Mex 16 123-130
  • [7] Altemani J(1993)Langerhans cell histiocytosis of the tonsil Laryngorhinootologie 72 346-349
  • [8] Queiroz LC(2013)Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine Ann Hematol 92 267-268
  • [9] Carvalho KL(2013)Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net Orphanet J Rare Dis 14 72-1057
  • [10] Pinkus GS(2009)Isolated adult Langerhans cell histiocytosis in cervical lymph nodes: should it be treated? J Laryngol Otol 123 1055-undefined